Reach Us +44-1474-556909
Prospective Evaluation Of Antimicrobial Prophylaxis And Other Risk Factors For Surgical Site Infection At Surgical Ward | 23517
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

7th European Biopharma Congress

Prague, Czech Republic

33rd World Congress on Pharmacology

Barcelona, Spain
Share This Page

Prospective evaluation of antimicrobial prophylaxis and other risk factors for surgical site infection at surgical ward

2nd International Summit on Clinical Pharmacy

Belay Yimam Yesuf

Posters: Clinic Pharmacol Biopharm

DOI: 10.4172/2167-065X.S1.007

Background: Appropriately administered surgical antimicrobial prophylaxis (AMP) reduces the incidence of surgical site infections (SSIs). However, inappropriate prescribing and excessive use of antimicrobials increase antimicrobials resistance as well as adverse drug events and costs. Objective: To determine the rate and predictors of SSI and evaluate surgical AMP administration against American Society of Health-System Pharmacists (ASHP) guideline on AMP in surgery at surgical ward of Jimma University Specialized Hospital (JUSH). Methods: A prospective cohort study was conducted on major surgical procedures from February ? April, 2012. The data were analyzed using SPSS version 16.0. Binary logistic regression analysis was conducted to identify factors and independent predictors associated with SSIs. P-value < 0.05 was considered to be statistically significant. Results: The rate of SSI was 12.2%. Total compliance to the guideline was not observed at all. AMP was indicated in 128 (71.1%) of all procedures but administered for 104 (81.2%) of those who required AMP. Choice of AMP was discordant at all and ceftriaxone was one of the most commonly used drugs. Timing of first dose was discordant in 92 (71.9%) of 128 procedures to which AMP was indicated. With regard to the duration of prophylaxis 98 (94.2%) was discordant with the guideline. AMP administration significantly reduced SSI (P = 0.005; OR= 6.2). Age greater than 60 years (P = 0.025; OR= 4.7), duration of surgery (P = 0.022; OR = 4.4), history of surgery in the previous one year (P = 0.013; OR = 7.3) and smoking (P = 0.008; OR= 8.8) were found to be independent predictors for SSI. Conclusions: SSI rate is lower than reports from other African countries but still higher than developed countries. Adherence to ASHP guideline is far from optimal.
Belay Yimam Yesuf is currently a Lecturer and Clinical pharmacist at Southern Africa Nazarene University (SANU), Swaziland. He received his MSc in Clinical Pharmacy at the age of 31 years from Jimma University. Before joining SANU 2 months back he worked at Jimma University as a Lecturer and Clinical pharmacist and taught courses for MSc clinical pharmacy & undergraduate students. He gave clinical service to the community at the hospital and supervised students during their clinical attachment at different patient wards. In addition, he gave in-service training on clinical pharmacy for pharmacist and also advising postgraduate and undergraduate pharmacy students in their independent research projects.